Vimarsana
Biggest News Aggregation in the World

Page 29 - Cancer Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cancer Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cancer Program Today - Breaking & Trending Today

Top Stories of 2023: Eric Montross' Cancer Fight Galvanizes the Community - Vimarsana News

Top Stories of 2023: Eric Montross' Cancer Fight Galvanizes the Community

To reflect on the year, Chapelboro.com is re-publishing some of the top stories that impacted and defined our community’s experience in 2023.

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors - Vimarsana News

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

Drs Simeone and Fakih discuss the main objective and design of the observational BASECAMP-1 study and how it functions alongside the EVEREST-1 study, which is evaluating the autologous CAR T-cell therapy A2B530 in patients with CEA-expressing solid tumors that have lost HLA-A*02 expression.

Dr Brufsky on the FDA Approval of Capivasertib Plus Fulvestrant in PIK3CA/AKT1/PTEN-Altered HR+/HER2– Breast Cancer - Vimarsana News

Dr Brufsky on the FDA Approval of Capivasertib Plus Fulvestrant in PIK3CA/AKT1/PTEN-Altered HR+/HER2– Breast Cancer

Adam M. Brufsky, MD, PhD, FACP, discusses the significance of the FDA approval of capivasertib in combination with fulvestrant for patients with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer harboring 1 or more PIK3CA, AKT1, or PTEN alterations.

Shop and savor the season - Family fun for the week of Dec. 15 - Vimarsana News

Shop and savor the season - Family fun for the week of Dec. 15

Family fun for the week of Dec. 15

Source: yahoo.com
Mapping The Genetic Landscape Of Lung Cancer - Vimarsana News

Mapping The Genetic Landscape Of Lung Cancer

An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.